NOPHO-ALL-2008 Treatment Protocol for Children (1.0 - 17.9 years of age) with Acute Lymphoblastic Leukemia.

Trial Profile

NOPHO-ALL-2008 Treatment Protocol for Children (1.0 - 17.9 years of age) with Acute Lymphoblastic Leukemia.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Cytarabine (Primary) ; Pegaspargase (Primary) ; Mercaptopurine; Methotrexate
  • Indications Acute lymphoblastic leukaemia
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 28 Feb 2017 Results (n=918) of DNA-TGN substudy assessing relationship between therapeutic efficacy and DNA-TGN concentration in blood leucocytes, published in the Lancet Oncology
    • 01 May 2016 This study is discontinued in Lithuania (03/04/2016) as per European Clinical Trials Database record.
    • 13 Jul 2012 Planned number of patients changed from 1500 to 1550 as reported by European Clinical Trials Database record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top